Maynard Um
-
-
-
-
-
-
-
Pfizer's LORBRENA shows 55% seven-year survival without progression
-
-
-
-
-
-
-
HHS downplays Hantavirus risk amid repatriation efforts
-
-
-
-
-
-
-
Pfizer (PFE) call put ratio 4.7 calls to 1 put quarter results
-
-
-
-
-
-
-
RBC Capital on BridgeBio Pharma (BBIO): 'we remain buyers'
-
-
-
-
-
-
-
Bristol Myers Squibb and Pfizer partner with Mark Cuban's Cost Plus Drugs
-
-
-
-
-
-
-
Pfizer (PFE) to shutter South S.F. research site, end Bay Area presence - Bloomberg
-
-
-
-
-
-
-
US Judge blocks Trump Admin cuts to number of routinely recommended vaccines for children - Reuters
-
401,543 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

